WALTHAM, Mass. - Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS), a company specializing in next-generation robotic technology for surgery, has scheduled the release of its financial results for the fourth quarter and the full year that ended on December 31, 2023. The announcement will be made after the market closes on March 4, 2024, followed by a conference call at 4:30 p.m. Eastern Time.
The call is accessible to interested investors, with domestic callers dialing +1 833 470 1428 and international callers using +1 404 975 4839, followed by the access code 608739. Additionally, both a live and archived webcast of the conference will be available for viewing on the Vicarious Surgical investor relations website.
Vicarious Surgical, founded in 2014 and headquartered in Waltham, Massachusetts, aims to enhance the efficiency and outcomes of surgical procedures while also aiming to reduce healthcare costs. The company's innovative approach involves the use of proprietary human-like surgical robots that provide surgeons with a virtual presence inside the patient, enabling minimally invasive surgery. The leadership team at Vicarious Surgical includes seasoned professionals from technology, medical device, and healthcare sectors.
The company has garnered attention and backing from notable figures in the technology and investment fields, including Bill Gates and entities such as Khosla Ventures, Innovation Endeavors, AME Cloud Ventures, Sun Hung Kai & Co. Ltd, and E15 VC.
The information mentioned is based on a press release statement from Vicarious Surgical Inc.
InvestingPro Insights
As Vicarious Surgical Inc. prepares to release its financial results, investors are closely monitoring the company's performance metrics and analyst insights. According to InvestingPro data, the company currently holds a market capitalization of $72.23 million. However, the financial health of Vicarious Surgical appears challenging, with an adjusted P/E ratio for the last twelve months as of Q3 2023 standing at -1.04, reflecting the company's lack of profitability during this period.
InvestingPro Tips highlight that Vicarious Surgical has more cash than debt on its balance sheet, which could provide a cushion for operational needs or strategic initiatives. Additionally, four analysts have revised their earnings projections upwards for the upcoming period, suggesting potential optimism about the company's future performance.
Nevertheless, it's important to note that Vicarious Surgical has been quickly burning through cash and suffers from weak gross profit margins. The company's stock price has also experienced significant volatility, with a 28.77% decline over the past month and an 87.01% drop over the last year, as of the date provided.
Investors interested in a deeper analysis can find additional InvestingPro Tips for Vicarious Surgical at https://www.investing.com/pro/RBOT. For those considering an InvestingPro subscription, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. There are 12 more tips available on InvestingPro that could provide further insights into Vicarious Surgical's financial health and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.